\-\ Texto\\:\\ \ \(0\)\
\-\ notable\\ only\\ for\\ 3x3\\.5cm\\ firm\\ nodule\\ in\\ level\\ 2\\ region\\.\\ \\ nasopharyngoscope\\ exam\\ was\\ benign\\.\ \(0\)\
\-\ this\\ patient\\ has\\ t2n2am0\\ or\\ stage\\ iva\\ disease\\.\\ \\ surgical\\ excision\\ or\\ combined\\ chemoradiation\\ are\\ the\\ accepted\\ treatment\\ options\\.\\ \\ given\\ liklihood\\ of\\ severe\\ morbidity\\ post\\-surgery\\,\\ patient\\ chose\\ chemoradiation\\.\\ \\ however\\,\\ left\\ neck\\ dissection\\ is\\ still\\ a\\ possibility\\.\\ \\ patient\\ will\\ have\\ imrt\\ m\\-f\\ for\\ about\\ 8\\ weeks\\ and\\ opted\\ for\\ amifostine\\ for\\ parotid\\ sparing\\.\\ \\ patient\\ will\\ have\\ lifetime\\ follow\\-up\\ to\\ monitor\\ for\\ recurrent\\ and\\ new\\ primary\\ disease\\.\ \(0\)\
\-\ neck\\ ct\\:\\ mass\\ adjacent\\ to\\ left\\ parotid\\ and\\ medial\\ to\\ digastric\\ measuring\\ 2\\.8\\ \\(ap\\)x\\ 1\\.6\\ \\(trans\\)x\\ 4\\.5cm\\(cc\\)\\.\\ \\ soft\\ tissue\\ asymmetry\\ superior\\ to\\ left\\ vallecula\\ \\-\\ mass\\ cannot\\ be\\ excluded\\.\ \(0\)\
\-\ neck\\ mri\\:\\ enhancing\\ plaque\\-like\\ mass\\ measuring\\ 0\\.9\\ x\\ 2\\.2\\ x\\ 3\\.4\\ cm\\ at\\ base\\ of\\ the\\ tongue\\.\\ \\ a\\ second\\ enhancing\\ mucosal\\ plaque\\-like\\ lesion\\ at\\ same\\ level\\ of\\ tongue\\ base\\ to\\ the\\ right\\ of\\ midline\\ measuring\\ 1\\.5cm\\ \\(trans\\)\\ x\\ 2\\.9cm\\ \\(cc\\)\\ x\\ 6mm\\ thick\\.\\ \\ masses\\ do\\ not\\ appear\\ to\\ extend\\ into\\ musculature\\ of\\ tongue\\.\\ \\ hemorrhagic\\ and\\ necrotic\\ lymph\\ node\\ in\\ level\\ 1\\ left\\ side\\ just\\ inferior\\ to\\ mandible\\ and\\ deep\\ portion\\ of\\ parotid\\ lateral\\ to\\ carotids\\ measuring\\ 3\\ x\\ 1\\.8\\ x\\ 3\\.8cm\\.\\ \\ second\\ necrotic\\ node\\ above\\ previous\\ measuring\\ 1\\.1\\ x\\ 1\\.3\\ x\\ 1\\.6cm\\.\ \(0\)\
\-\ oropharyngeal\\ \\(tongue\\)\\ cancer\\,\\ squamous\\ cell\\ carcinoma\\ \\(scc\\)\ \(0\)\
\-\ \\Â\\»\\ neoplasm\\ \\-\\ primary\\ vs\\ metastatic\ \(0\)\
\-\ \\Â\\»\\ infection\ \(0\)\
\-\ \\Â\\»\\ connective\\ tissue\\ disorder\ \(0\)\
\-\ \\Â\\»\\ vasculitis\ \(0\)\
\-\ \\Â\\»\\ other\\ autoimmune\\ disease\ \(0\)\
\-\ \\Â\\»\\ other\\ inflammatory\\ process\ \(0\)\
\-\ hpi\\:\\ presented\\ with\\ a\\ 6\\ month\\ hisotry\\ of\\ an\\ asymptomatic\\ left\\ neck\\ mass\\ s\\/p\\ failed\\ course\\ of\\ abx\\ therapy\\ and\\ two\\ non\\-diagnostic\\ fnas\\.\ \(0\)\
\-\ pmh\\:\\ denies\\ any\\ h\\/o\\ ca\\,\\ xrt\\,\\ chemo\\.\\ \\ denies\\ any\\ h\\/o\\ heart\\ dz\\,\\ lung\\ dz\\,\\ dm\\,\\ sle\\,\\ scleroderma\\,\\ or\\ ibd\\.\ \(0\)\
\-\ psh\\:\\ t\\&a\\ at\\ 6\\;\\ btl\\ at\\ 41\\;\\ right\\ foot\\ surgery\\ at\\ 51\\.\ \(0\)\
\-\ fhx\\:\\ mom\\ h\\/o\\ uterine\\ and\\ colon\\ ca\\;\\ 3\\ sisters\\ h\\/o\\ breast\\ ca\\;\\ sister\\ h\\/o\\ uterine\\ ca\\;\\ sister\\ h\\/o\\ breast\\ and\\ kidney\\ ca\\,\\ died\\ at\\ 52\\;\\ brother\\ died\\ of\\ lung\\ ca\\ at\\ 52\ \(0\)\
\-\ allergies\\:\\ nkda\ \(0\)\
\-\ meds\\:\\ tylenol\ \(0\)\
\-\ shx\\:\\ g4p4\\,\\ postmenopausal\\;\\ lifetime\\ non\\-smoker\\,\\ non\\-drinker\\;\\ no\\ significant\\ travel\\ or\\ occupational\\ exposure\\ history\ \(0\)\
\-\ ros\\:\\ pos\\ for\\ globus\\ sensation\\.\\ \\ denies\\ weight\\ loss\\,\\ pain\\,\\ hoarseness\\,\\ dysphagia\\,\\ constitutional\\ symptoms\\.\ \(0\)\
\-\ this\\ patient\\ is\\ unique\\ given\\ a\\ lack\\ of\\ any\\ classic\\ risk\\ factors\\ for\\ oropharyngeal\\ cancer\\.\\ \\ however\\,\\ her\\ extensive\\ family\\ history\\ of\\ cancer\\ raises\\ the\\ question\\ of\\ a\\ familial\\ risk\\ factor\\.\\ \\ although\\ oropharyngeal\\ squamous\\ cell\\ carcinoma\\ is\\ not\\ classically\\ related\\ to\\ any\\ of\\ the\\ other\\ cancers\\ her\\ mother\\ and\\ siblings\\ sufferred\\ from\\,\\ the\\ same\\ overexpression\\ or\\ underexpression\\ of\\ cell\\ cycle\\ regulators\\ and\\ tumor\\ suppressors\\ implicated\\ in\\ the\\ pathogenesis\\ of\\ those\\ cancers\\ are\\ being\\ studied\\ as\\ playing\\ a\\ role\\ in\\ oropharyngeal\\ carcinogenesis\\ as\\ well\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ x\\:\\ 0\\.05571277342583947\ \(0\)\
\-\ h\\/o\\:\\ 0\\.05287126004676174\ \(0\)\
\-\ oropharyngeal\\:\\ 0\\.050044361851213415\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.04992507792069256\ \(0\)\
\-\ ca\\:\\ 0\\.0471846227314034\ \(0\)\
\-\ tongue\\:\\ 0\\.04114308704602587\ \(0\)\
\-\ parotid\\:\\ 0\\.034504660970825135\ \(0\)\
\-\ measuring\\:\\ 0\\.03376833717834729\ \(0\)\
\-\ \\;\\:\\ 0\\.0320224693826497\ \(0\)\
\-\ chemoradiation\\:\\ 0\\.03050160527785924\ \(0\)\
\-\ plaque\\-like\\:\\ 0\\.028482531666135957\ \(0\)\
\-\ trans\\:\\ 0\\.027761893101732976\ \(0\)\
\-\ lifetime\\:\\ 0\\.02662480981140973\ \(0\)\
\-\ dz\\:\\ 0\\.024705806586976128\ \(0\)\
\-\ sister\\:\\ 0\\.023419552039803688\ \(0\)\
\-\ \\:\\:\\ 0\\.022337446956337253\ \(0\)\
\-\ denies\\:\\ 0\\.021379637971097296\ \(0\)\
\-\ any\\:\\ 0\\.02127142318634224\ \(0\)\
\-\ cancers\\:\\ 0\\.020363465525046844\ \(0\)\
\-\ neck\\:\\ 0\\.01983591412662832\ \(0\)\
\-\ died\\:\\ 0\\.019797849542277385\ \(0\)\
\-\ necrotic\\:\\ 0\\.018467919753260734\ \(0\)\
\-\ cc\\:\\ 0\\.018108347507388295\ \(0\)\
\-\ 52\\:\\ 0\\.01799540927638412\ \(0\)\
\-\ 3x3\\.5cm\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ t2n2am0\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ m\\-f\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ amifostine\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ hisotry\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ btl\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ 51\\.\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ shx\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ g4p4\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ sufferred\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ underexpression\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ regulators\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ suppressors\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ uterine\\:\\ 0\\.017330836462937486\ \(0\)\
\-\ cancer\\:\\ 0\\.016655130025878054\ \(0\)\
\-\ squamous\\:\\ 0\\.01652485942978997\ \(0\)\
\-\ nasopharyngoscope\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ liklihood\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ imrt\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ digastric\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ vallecula\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ 2\\.9cm\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ 3\\.8cm\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ fnas\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ non\\-drinker\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ pos\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ overexpression\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ carcinogenesis\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ at\\:\\ 0\\.016016486303994923\ \(0\)\
\-\ node\\:\\ 0\\.015455508480348096\ \(0\)\
\-\ sisters\\:\\ 0\\.01525080263892962\ \(0\)\
\-\ level\\:\\ 0\\.01460210885956679\ \(0\)\
\-\ iva\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ chose\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ 4\\.5cm\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ non\\-diagnostic\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ same\\:\\ 0\\.01392179288237947\ \(0\)\
\-\ 1\\.5cm\\:\\ 0\\.013880946550866488\ \(0\)\
\-\ postmenopausal\\:\\ 0\\.013880946550866488\ \(0\)\
\-\ cell\\:\\ 0\\.013685221610166914\ \(0\)\
\-\ 1\\.6cm\\:\\ 0\\.013576300938559653\ \(0\)\
\-\ studied\\:\\ 0\\.013576300938559653\ \(0\)\
\-\ post\\-surgery\\:\\ 0\\.013312404905704865\ \(0\)\
\-\ fhx\\:\\ 0\\.013312404905704865\ \(0\)\
\-\ base\\:\\ 0\\.01323106040644809\ \(0\)\
\-\ accepted\\:\\ 0\\.013079632107964976\ \(0\)\
\-\ opted\\:\\ 0\\.013079632107964976\ \(0\)\
\-\ hpi\\:\\ 0\\.013079632107964976\ \(0\)\
\-\ siblings\\:\\ 0\\.013079632107964976\ \(0\)\
\-\ second\\:\\ 0\\.012972841641260781\ \(0\)\
\-\ non\\-smoker\\:\\ 0\\.012871409745004846\ \(0\)\
\-\ implicated\\:\\ 0\\.012871409745004846\ \(0\)\
\-\ abx\\:\\ 0\\.012511090462803354\ \(0\)\
\-\ chemo\\:\\ 0\\.012511090462803354\ \(0\)\
\-\ breast\\:\\ 0\\.012460703335298624\ \(0\)\
\-\ 0\\.9\\:\\ 0\\.012352903293488064\ \(0\)\
\-\ carotids\\:\\ 0\\.012352903293488064\ \(0\)\
\-\ risk\\:\\ 0\\.012234018369008247\ \(0\)\
\-\ brother\\:\\ 0\\.012206444850496519\ \(0\)\
\-\ scc\\:\\ 0\\.012070095302103335\ \(0\)\
\-\ ibd\\:\\ 0\\.011942548817641731\ \(0\)\
\-\ psh\\:\\ 0\\.011942548817641731\ \(0\)\
\-\ nkda\\:\\ 0\\.011942548817641731\ \(0\)\
\-\ globus\\:\\ 0\\.011942548817641731\ \(0\)\
\-\ raises\\:\\ 0\\.011822737312075655\ \(0\)\
\-\ other\\:\\ 0\\.011677698905350484\ \(0\)\
\-\ travel\\:\\ 0\\.011602923803952683\ \(0\)\
\-\ pathogenesis\\:\\ 0\\.011602923803952683\ \(0\)\
\-\ given\\:\\ 0\\.011578713013898586\ \(0\)\
\-\ 2\\.8\\:\\ 0\\.011501553656941712\ \(0\)\
\-\ xrt\\:\\ 0\\.011501553656941712\ \(0\)\
\-\ mom\\:\\ 0\\.01140513040759501\ \(0\)\
\-\ tylenol\\:\\ 0\\.01140513040759501\ \(0\)\
\-\ 3\\.4\\:\\ 0\\.011313193617802732\ \(0\)\
\-\ occupational\\:\\ 0\\.011313193617802732\ \(0\)\
\-\ ros\\:\\ 0\\.011313193617802732\ \(0\)\
\-\ hoarseness\\:\\ 0\\.011313193617802732\ \(0\)\
\-\ 2\\.2\\:\\ 0\\.011141234374740221\ \(0\)\
\-\ constitutional\\:\\ 0\\.011141234374740221\ \(0\)\
\-\ 6mm\\:\\ 0\\.011060558496241693\ \(0\)\
\-\ cycle\\:\\ 0\\.011060558496241693\ \(0\)\
\-\ 1\\.3\\:\\ 0\\.010908461577000334\ \(0\)\
\-\ 1\\.8\\:\\ 0\\.010836588762433387\ \(0\)\
\-\ autoimmune\\:\\ 0\\.010767238328023761\ \(0\)\
\-\ unique\\:\\ 0\\.010767238328023761\ \(0\)\
\-\ dm\\:\\ 0\\.010700239214040203\ \(0\)\
\-\ scleroderma\\:\\ 0\\.010700239214040203\ \(0\)\
\-\ enhancing\\:\\ 0\\.010592701711006952\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.010572692729578599\ \(0\)\
\-\ asymmetry\\:\\ 0\\.010572692729578599\ \(0\)\
\-\ will\\:\\ 0\\.010567118649719928\ \(0\)\
\-\ 1\\.1\\:\\ 0\\.01051187917490122\ \(0\)\
\-\ musculature\\:\\ 0\\.010395593601733368\ \(0\)\
\-\ meds\\:\\ 0\\.010395593601733368\ \(0\)\
\-\ familial\\:\\ 0\\.010339919931838712\ \(0\)\
\-\ morbidity\\:\\ 0\\.010285771761506468\ \(0\)\
\-\ \\,\\:\\ 0\\.010165002460135296\ \(0\)\
\-\ her\\:\\ 0\\.010155777306264567\ \(0\)\
\-\ 6\\:\\ 0\\.010087431467884878\ \(0\)\
\-\ for\\:\\ 0\\.010086476364622541\ \(0\)\
\-\ sle\\:\\ 0\\.01008289793925334\ \(0\)\
\-\ sparing\\:\\ 0\\.010035274319531875\ \(0\)\
\-\ primary\\:\\ 0\\.010005471394844648\ \(0\)\
\-\ \\(\\:\\ 0\\.009993146410488188\ \(0\)\
\-\ mandible\\:\\ 0\\.009988771360223192\ \(0\)\
\-\ role\\:\\ 0\\.009988771360223192\ \(0\)\
\-\ connective\\:\\ 0\\.009943337529739598\ \(0\)\
\-\ allergies\\:\\ 0\\.009898924771138693\ \(0\)\
\-\ or\\:\\ 0\\.009896469851420035\ \(0\)\
\-\ \\)\\:\\ 0\\.009871074792081295\ \(0\)\
\-\ classically\\:\\ 0\\.009855488196595657\ \(0\)\
\-\ lung\\:\\ 0\\.009783237629402157\ \(0\)\
\-\ question\\:\\ 0\\.009690702408178561\ \(0\)\
\-\ monitor\\:\\ 0\\.0096131911173618\ \(0\)\
\-\ carcinoma\\:\\ 0\\.009572836640378918\ \(0\)\
\-\ left\\:\\ 0\\.0094476805264122\ \(0\)\
\-\ failed\\:\\ 0\\.00943175327298804\ \(0\)\
\-\ however\\:\\ 0\\.00940461682054178\ \(0\)\
\-\ mass\\:\\ 0\\.009394948671522248\ \(0\)\
\-\ notable\\:\\ 0\\.00933038312597707\ \(0\)\
\-\ combined\\:\\ 0\\.00933038312597707\ \(0\)\
\-\ excluded\\:\\ 0\\.009142023086838086\ \(0\)\
\-\ 41\\:\\ 0\\.00899770463819206\ \(0\)\
\-\ playing\\:\\ 0\\.00899770463819206\ \(0\)\
\-\ thick\\:\\ 0\\.008863211627826417\ \(0\)\
\-\ exposure\\:\\ 0\\.008786700734188689\ \(0\)\
\-\ mucosal\\:\\ 0\\.008713041851190206\ \(0\)\
\-\ vasculitis\\:\\ 0\\.00864202997524937\ \(0\)\
\-\ factor\\:\\ 0\\.00861891527216006\ \(0\)\
\-\ possibility\\:\\ 0\\.008529068683075559\ \(0\)\
\-\ patient\\:\\ 0\\.008464347143442569\ \(0\)\
\-\ extend\\:\\ 0\\.008464266661686249\ \(0\)\
\-\ pmh\\:\\ 0\\.008401522198613957\ \(0\)\
\-\ dissection\\:\\ 0\\.008301181634634858\ \(0\)\
\-\ firm\\:\\ 0\\.008281710693047879\ \(0\)\
\-\ disease\\:\\ 0\\.008281052615903384\ \(0\)\
\-\ dysphagia\\:\\ 0\\.008224423070768726\ \(0\)\
\-\ options\\:\\ 0\\.008205690375206385\ \(0\)\
\-\ still\\:\\ 0\\.008044636947832506\ \(0\)\
\-\ tissue\\:\\ 0\\.008005617345662425\ \(0\)\
\-\ 3\\:\\ 0\\.007908994176705689\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.00787985115941541\ \(0\)\
\-\ t\\:\\ 0\\.007817600829258548\ \(0\)\
\-\ sensation\\:\\ 0\\.007757251572618072\ \(0\)\
\-\ mother\\:\\ 0\\.007713169047886257\ \(0\)\
\-\ lack\\:\\ 0\\.007684317665631014\ \(0\)\
\-\ those\\:\\ 0\\.007684317665631014\ \(0\)\
\-\ to\\:\\ 0\\.0075960730750728785\ \(0\)\
\-\ disorder\\:\\ 0\\.007586530991197477\ \(0\)\
\-\ factors\\:\\ 0\\.007586530991197477\ \(0\)\
\-\ do\\:\\ 0\\.007331171838074935\ \(0\)\
\-\ not\\:\\ 0\\.007321059318628075\ \(0\)\
\-\ have\\:\\ 0\\.007313984499466766\ \(0\)\
\-\ \\-\\:\\ 0\\.007240033433629895\ \(0\)\
\-\ stage\\:\\ 0\\.007203625353613332\ \(0\)\
\-\ recurrent\\:\\ 0\\.007126545990365765\ \(0\)\
\-\ s\\/p\\:\\ 0\\.007083813848047255\ \(0\)\
\-\ just\\:\\ 0\\.007052360379063265\ \(0\)\
\-\ foot\\:\\ 0\\.006980859081479268\ \(0\)\
\-\ related\\:\\ 0\\.006970852555873444\ \(0\)\
\-\ nodule\\:\\ 0\\.006960896441189735\ \(0\)\
\-\ excision\\:\\ 0\\.006931325546571726\ \(0\)\
\-\ family\\:\\ 0\\.006921566096689151\ \(0\)\
\-\ appear\\:\\ 0\\.006911854604984747\ \(0\)\
\-\ deep\\:\\ 0\\.006835834287143252\ \(0\)\
\-\ lymph\\:\\ 0\\.006817277488032898\ \(0\)\
\-\ extensive\\:\\ 0\\.006753667435669457\ \(0\)\
\-\ vs\\:\\ 0\\.00664916990197786\ \(0\)\
\-\ colon\\:\\ 0\\.006632278477909761\ \(0\)\
\-\ previous\\:\\ 0\\.006558004345204142\ \(0\)\
\-\ midline\\:\\ 0\\.006533853927546483\ \(0\)\
\-\ about\\:\\ 0\\.006509995071352276\ \(0\)\
\-\ process\\:\\ 0\\.006502105701254376\ \(0\)\
\-\ classic\\:\\ 0\\.006470859444284727\ \(0\)\
\-\ course\\:\\ 0\\.0063725917854854566\ \(0\)\
\-\ 8\\:\\ 0\\.006314461577567882\ \(0\)\
\-\ above\\:\\ 0\\.006189602088197265\ \(0\)\
\-\ ap\\:\\ 0\\.00617620349731707\ \(0\)\
\-\ portion\\:\\ 0\\.006117009184504123\ \(0\)\
\-\ weight\\:\\ 0\\.006053252539804081\ \(0\)\
\-\ kidney\\:\\ 0\\.005949374417094881\ \(0\)\
\-\ \\&\\:\\ 0\\.005931596624785438\ \(0\)\
\-\ new\\:\\ 0\\.0058849564758904314\ \(0\)\
\-\ being\\:\\ 0\\.0058849564758904314\ \(0\)\
\-\ heart\\:\\ 0\\.005867746341716945\ \(0\)\
\-\ inflammatory\\:\\ 0\\.005856355620932853\ \(0\)\
\-\ side\\:\\ 0\\.005850684786095002\ \(0\)\
\-\ benign\\:\\ 0\\.005828162780698026\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0057512975808536124\ \(0\)\
\-\ inferior\\:\\ 0\\.005729874231934906\ \(0\)\
\-\ masses\\:\\ 0\\.005708680628450765\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.005708680628450765\ \(0\)\
\-\ although\\:\\ 0\\.005703417550546647\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.005494144251861149\ \(0\)\
\-\ a\\:\\ 0\\.005486558523182231\ \(0\)\
\-\ medial\\:\\ 0\\.005401777694842\ \(0\)\
\-\ superior\\:\\ 0\\.00539277410485018\ \(0\)\
\-\ adjacent\\:\\ 0\\.005339597320423452\ \(0\)\
\-\ severe\\:\\ 0\\.005196264427007913\ \(0\)\
\-\ as\\:\\ 0\\.005109001999581532\ \(0\)\
\-\ only\\:\\ 0\\.0050778886531322835\ \(0\)\
\-\ month\\:\\ 0\\.005066431898815433\ \(0\)\
\-\ infection\\:\\ 0\\.004909123664175508\ \(0\)\
\-\ loss\\:\\ 0\\.004902103107645137\ \(0\)\
\-\ two\\:\\ 0\\.004836622999241117\ \(0\)\
\-\ weeks\\:\\ 0\\.004793039045259186\ \(0\)\
\-\ region\\:\\ 0\\.004769962899682435\ \(0\)\
\-\ history\\:\\ 0\\.004664879595680171\ \(0\)\
\-\ are\\:\\ 0\\.004604244555452971\ \(0\)\
\-\ presented\\:\\ 0\\.0046034735870008085\ \(0\)\
\-\ significant\\:\\ 0\\.004541199903269216\ \(0\)\
\-\ cm\\:\\ 0\\.004529557545092857\ \(0\)\
\-\ therapy\\:\\ 0\\.004515100387827298\ \(0\)\
\-\ metastatic\\:\\ 0\\.00425120435497251\ \(0\)\
\-\ symptoms\\:\\ 0\\.004208809242881697\ \(0\)\
\-\ soft\\:\\ 0\\.004112503486153261\ \(0\)\
\-\ surgery\\:\\ 0\\.004100788664743626\ \(0\)\
\-\ into\\:\\ 0\\.004018431557232622\ \(0\)\
\-\ 1\\:\\ 0\\.004018431557232622\ \(0\)\
\-\ tumor\\:\\ 0\\.003937217987373145\ \(0\)\
\-\ mri\\:\\ 0\\.0038799918081316594\ \(0\)\
\-\ can\\:\\ 0\\.003830478957448754\ \(0\)\
\-\ well\\:\\ 0\\.0038203180888708517\ \(0\)\
\-\ this\\:\\ 0\\.0037989613174471658\ \(0\)\
\-\ exam\\:\\ 0\\.0037099484979239883\ \(0\)\
\-\ lateral\\:\\ 0\\.00364954159214338\ \(0\)\
\-\ 2\\:\\ 0\\.0036365701512066128\ \(0\)\
\-\ right\\:\\ 0\\.0035637616960886034\ \(0\)\
\-\ and\\:\\ 0\\.0035574902318620248\ \(0\)\
\-\ surgical\\:\\ 0\\.0035498453957538605\ \(0\)\
\-\ of\\:\\ 0\\.0034536699841300916\ \(0\)\
\-\ lesion\\:\\ 0\\.003439832462451491\ \(0\)\
\-\ treatment\\:\\ 0\\.0034182153351796185\ \(0\)\
\-\ is\\:\\ 0\\.003333739792794816\ \(0\)\
\-\ in\\:\\ 0\\.0033312034003182204\ \(0\)\
\-\ has\\:\\ 0\\.003171343815206083\ \(0\)\
\-\ be\\:\\ 0\\.002604262299098674\ \(0\)\
\-\ from\\:\\ 0\\.002502837377775123\ \(0\)\
\-\ ct\\:\\ 0\\.0023622601845692546\ \(0\)\
\-\ an\\:\\ 0\\.0023353060558986755\ \(0\)\
\-\ pain\\:\\ 0\\.0020624667342504636\ \(0\)\
\-\ was\\:\\ 0\\.001953117632833373\ \(0\)\
\-\ the\\:\\ 0\\.0019125395117102382\ \(0\)\
\-\ no\\:\\ 0\\.0017004825112723358\ \(0\)\
\-\ \\.\\:\\ 0\\.0016136152771521035\ \(0\)\
\-\ with\\:\\ 0\\.00023123354958476232\ \(0\)\
